Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic screening for SSRI drug response among those with major depression: great promise and unseen perils.

Depression and anxiety - 1 Jan 2007

Rasmussen-Torvik Laura J, McAlpine Donna D

Abstract excerpt

This article examines evidence for the potential benefit of genetic testing for SSRI response, as well as potential ethical and practical implications of the implementation of this test into standard psychiatric practice. We reviewed three areas of the literature: the burden of treatment-resistant and treatment-intolerant major depressive disorders, the evidence for the value of genetic testing to predict drug...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents, Second-Generation
Share to Cytochrome P-450 CYP2D6

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Depressive Disorder, Major

Share to Ethics, Medical

Share to Genetic Privacy

Share to Patient Compliance

Share to Selective Serotonin Reuptake Inhibitors

Share to Serotonin Plasma Membrane Transport Proteins

Source

Identifiers

PMID: 17096399
DOI: 10.1002/da.20251

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic screening for SSRI drug response among those with major depression: great promise and unseen perils.PMID 17096399Read ↗

Understanding the genetic aspects of resistance to antidepressants treatment.Semantic proximity Read ↗

Pharmacogenetics testing for poor response to antidepressants: a transnosographic case seriesSemantic proximity Read ↗

Pharmacogenetics of antidepressant drugs: current clinical practice and future directions.Semantic proximity Read ↗

Implications of the use of genetic tests in psychiatry, with a focus on major depressive disorder: a review.Semantic proximity Read ↗

Genome-wide meta-analyses of non-response to antidepressants provide insights into underlying molecular genetics and suggest potential pharmacotherapies.Semantic proximity Read ↗

Assessment of human serotonin 1A receptor polymorphisms and SSRI responsiveness.Semantic proximity Read ↗

The Role of Genetics in the Development and Pharmacotherapy of Depression and Its Impact on Drug DiscoverySemantic proximity Read ↗

Antidepressant pharmacogeneticsSemantic proximity Read ↗

Review of evidence for genetic testing for CYP450 polymorphisms in management of patients with nonpsychotic depression with selective serotonin reuptake inhibitors.Semantic proximity Read ↗

Testing for cytochrome P450 polymorphisms in adults with non-psychotic depression treated with selective serotonin reuptake inhibitors (SSRIs).Semantic proximity Read ↗

Pharmacogenetics of Selective Serotonin Reuptake Inhibitor Response in Major Depression.Semantic proximity Read ↗

Genetic prediction of antidepressant drug response and nonresponse in Korean patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.